Intraperitoneal α-interferon alternating with cisplatin in residual ovarian carcinoma:: A phase II Gynecologic Oncology Group study
Intraperitoneal α-interferon alternating with cisplatin in residual ovarian carcinoma:: A phase II Gynecologic Oncology Group study
复制标题
DOI：
10.1006/gyno.1999.5455
复制
发表时间：
1999-07-01
影响因子：
4.7
通讯作者：
Hanjani, P
中科院分区：
文献类型：
--
作者：
Berek, JS;Markman, M;Hanjani, P
objective.本研究的目的是研究联合腹腔内α-干扰素和顺铂给药二线在一个交替的序列在小体积残留上皮性卵巢癌二次探查手术后，这种组合的活性的基础上，以前的反应一线铂化合物。62例残留量极小的患者（
Objective. The aim of this study was to study the combination of intraperitoneal alpha-interferon and cisplatin administered second-line in an alternating sequence in small volume residual epithelial ovarian cancer after second-look surgery and the activity of this combination based on prior response to first-line platinum compounds.Methods. Sixty-two patients with minimal residual(